Faslodex?

See the DrugPatentWatch profile for Faslodex

What is Faslodex used for?

Faslodex (fulvestrant) is used to treat certain types of hormone-receptor–positive breast cancer in people for whom endocrine (hormone) therapy is appropriate [1].

How does Faslodex work?

Faslodex is a selective estrogen receptor degrader (SERD). It binds to the estrogen receptor in breast cancer cells and promotes receptor degradation, which reduces estrogen signaling [1].

How is Faslodex given?

Faslodex is administered by injection [1].

What are common side effects people ask about?

Common side effects include injection-site reactions and symptoms that can occur with hormone-receptor targeting therapies. The exact side-effect profile and frequency depend on the specific breast cancer setting and regimen [1].

Who makes Faslodex, and is there more than one brand?

Faslodex is a brand-name medicine; it contains the active ingredient fulvestrant [1].

What should patients discuss with their clinician before starting?

Patients typically review their hormone-receptor status, prior endocrine therapies, and overall treatment plan. They also discuss prior adverse reactions to injections or endocrine therapies, and any other medical conditions that could affect treatment decisions [1].

Sources

1. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200706